International Research Consortium on Dengue Risk Assessment, Management, and Surveillance (IDAMS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01550016 |
Recruitment Status :
Completed
First Posted : March 9, 2012
Last Update Posted : October 11, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Dengue Fever | Other: Observation |
Study Type : | Observational |
Actual Enrollment : | 7411 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Clinical Evaluation of Dengue and Identification of Risk Factors for Severe Disease (WP1) |
Study Start Date : | October 2011 |
Actual Primary Completion Date : | June 2016 |
Actual Study Completion Date : | October 2016 |

Group/Cohort | Intervention/treatment |
---|---|
Febrile Patients
Observation of patients with possible dengue fever in the early phase of disease
|
Other: Observation
Clinical follow-up and laboratory investigations. |
- Hospitalization or administration of IV fluid [ Time Frame: 14 days ]Proportion of dengue patients hospitalized or treated with IV fluids within 14 days of enrollment.
- Development of severe disease [ Time Frame: 14 days ]Development of severe disease according to the 2009 WHO Dengue classification within 14 days of enrollment.
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 5 Years and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- >= 5 years of age
- fever for less than 72 hours
Exclusion Criteria:
- presence of localizing signs suggestive of another diagnosis
- not likely to come back for daily follow-up
- complications or signs of severe disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01550016
Bangladesh | |
International Centre for Diarrhoeal Diseases | |
Dhaka, Bangladesh, 1212 | |
Brazil | |
Fundacao Universidade Estadual do Ceara | |
Fortaleza, Brazil | |
Fundacao Oswaldo Cruz (FIOCRUZ) | |
Rio de Janeiro, Brazil | |
Cambodia | |
Angkor Hospital for Children | |
Siem Reap, Cambodia | |
El Salvador | |
Hospital National de Ninos Benjamin Bloom | |
San Salvador, El Salvador | |
Indonesia | |
Gadjah Madah University | |
Yogyakarta, Indonesia | |
Malaysia | |
University of Malaya Medical Centre | |
Kuala Lumpur, Malaysia | |
Venezuela | |
Universidad de Carabobo | |
Valencia, Venezuela | |
Vietnam | |
Oxford University Clinical Research Unit | |
Ho Chi Minh City, Vietnam |
Principal Investigator: | Thomas Jänisch | Heidelberg University Medical Center |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Thomas Jaenisch, Principal Investigator, University of Heidelberg Medical Center |
ClinicalTrials.gov Identifier: | NCT01550016 |
Other Study ID Numbers: |
281803 (EU FP7-HEALTH-2011) |
First Posted: | March 9, 2012 Key Record Dates |
Last Update Posted: | October 11, 2016 |
Last Verified: | October 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
dengue warning signs latin america south east asia other febrile illnesses dengue classification |
Dengue Arbovirus Infections Virus Diseases Flavivirus Infections |
Flaviviridae Infections RNA Virus Infections Hemorrhagic Fevers, Viral |